Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair

Recent advances in the differentiation and production of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) have stimulated development of strategies to use these cells in human cardiac regenerative therapies. A prerequisite for clinical trials and translational implementation of hPSC-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunn, Kaitlin K., Palecek, Sean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928319/
https://www.ncbi.nlm.nih.gov/pubmed/29740580
http://dx.doi.org/10.3389/fmed.2018.00110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928319/
https://www.ncbi.nlm.nih.gov/pubmed/29740580
http://dx.doi.org/10.3389/fmed.2018.00110

Ejemplares similares